The major factors attributing to the growth of the market are the increasing number of disabling hearing loss cases, rising geriatric population indirectly contributing to increased awareness of these devices, and increasing technological advancements by the companies. As per the revised World Population Prospects, by the United Nations, the number of people aged 60 or above is expected to grow greater than double by 2050, i.e. from 962 million in 2017 to 2.1 billion in 2050, worldwide. This age group is much more vulnerable to hearing loss, which boosts the demand for these devices in the market. According to “The Global Burden of Disease Study 2017” Disease and Injury Incidence and Prevalence Collaborators report, the estimated population with hearing loss rose from 1.2 billion (17.2%) in 2008 to 1.4 billion (18.7%) in 2017, for whom proper well-coordinated global action is needed.

The report provides market dynamics and trends related to the global electroencephalography equipment market. In addition, it presents the market estimations and forecast of the market. For the purpose of analysis, the global electroencephalography equipment market has been segmented based on product, application, end users and region. The report includes the revenue generated from the sales of products such as integrated EEG systems, portable EEG systems and EEG accessories, which are used for performing electroencephalograms. However, the report does not include revenue generated from the services provided by companies that conduct electroencephalograms. Moreover, for a further clarification the report also provides a broad view of the applications of the EEG products such as brain monitoring, sleep monitoring, and anesthesia monitoring, research and others. The market is also classified into end users such as hospitals, diagnostic centers, ambulatory surgical centers and others that utilize the products. This further provides the understanding about the use of EEG products. Furthermore, the report covers revenue generated from the sales of products related to electroencephalography equipment offered in regions such as North America, Europe, Asia-Pacific, and LAMEA

The factors driving the overall market growth include increasing number of cancer patients, reduction in the cost of radiotherapy, and rising government and non-government investments in research and development of cancer treatment. Increasing number of cancer reported cases have been the primary factor for the demand for radiotherapy. According to World Health Organization (WHO) 2018 data on cancer, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. The report suggests that there may be 27.5 million new cancer cases worldwide each year by 2040. As a result of rising cancer cases, government and non-government organizations have been investing in cancer research. Organizations, like Cancer Research UK (CRUK), has been actively involved in this pursuit for finding effective therapies, spending more than GBP 400 million a year on cancer research. Economies worldwide have also developed strategies to reduce the cost of radiotherapy, especially in middle-income and low-income economies. These strategies have helped the economies to save up to 50% cost for radiotherapy. These factors have positively affected and helped the growth of the market.

Neurological diseases are frequent in older adults, affecting around 55% of people aged 55 and older. They are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization, and hospitalization. Neurological diseases, like dementia and Parkinson’s disease, and strokes and headaches, are frequently encountered n eurological diseases in el derly patien ts. Neuromodula tion is an in tracranial, el ectrical neuromodulation therapy that has FDA approval for the treatment for several of the neurological diseases, such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most found in the elderly population. There are multiple ways through which funding organizations, research teams, and non-profit organizations are collaborating with consumers to raise the awareness regarding this neurological diseases, globally. The educational campaigns also play a demanding role in making patients and families aware of the neurological diseases, particularly in the middle and low-income nations, where the focus of the government and healthcare facilities are geared more toward major disorders, such as Parkinson’s disease and Alzheimer's disease.

Neurology devices are used for the diagnosis and treatment of various neurological disorders. The report of the neurology devices market involves the study of different types of devices, including neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. In addition, it covers the end users of the market, including hospitals, neurological clinics, and ambulatory care centers. Moreover, this report provides a detailed analysis of the current market trends and future estimations from 2019 to 2026.

The report provides market dynamics and trends related to the global nephrology devices market. In addition, it presents the market estimations and forecast of the market. It includes revenue generated from the sales of devices such as dialysis instrument, lithotripter, dialysis catheters, and other products, which are provided by key players. For the purpose of analysis, the global nephrology devices market is segmented into device type and region. The study estimates revenue generated from the sales of nephrology devices. On the basis of device type, the market is divided into dialysis instrument, lithotripter, dialysis catheters, and others. This further provides an understanding of the use of nephrology devices. Moreover, the report covers revenue generated from the sales of nephrology devices offered across regions such as North America, Europe, Asia-Pacific, and LAMEA.

The growth of the market studied is currently being driven by various factors, including the increasing pet ownership and animal health expenditure, increased burden of animal zoonotic diseases, and the growing pet insurance and animal health investments made by the pharmaceutical companies.  The recent years have observed an increasing adoption of pet animals every year. Not only the pet ownership, but also the number of farm population has increased at a steady rate. There is also a high adoption of pigs across billions of farms all over the world.  Moreover, there is an increase in the immune mediated diseases in animals, which has driven the market for new immunodiagnostic tests. ELISA is a highly sensitive means of detecting relatively low levels of molecules within a biological fluid. For this reason, it is a very commonly used immunodiagnostic test and is applied to a wide variety of samples from different body fluids.

The report provides market dynamics and trends related to the global veterinary imaging market. In addition, it presents the estimations and forecast of the market. The study estimates the revenue generated from the sales of veterinary imaging; however, it excludes the veterinary imaging service revenue. The valuations comprise revenue generated from veterinary imaging product such as instruments and reagent. Conversely, the report excludes revenue generated from post-sale services of veterinary imaging. For the purpose of analysis, the global veterinary imaging market is segmented into product, animal type, application, and region. The study estimates the revenue generated from the sales of instruments and reagent. The applications covered in the study include orthopedics & traumatology, oncology, cardiology, neurology, and other. The report covers the revenue generated from the sales of products related to veterinary imaging systems offered in regions such as North America, Europe, Asia-Pacific, and LAMEA.